We need you! Join our contributor community and become a WikEM editor through our open and transparent promotion process.
User contributions
- 11:55, 30 January 2016 (diff | hist) . . (+184) . . Procainamide (→Special Populations)
- 11:49, 30 January 2016 (diff | hist) . . (+171) . . Procainamide (→Pharmacology)
- 11:44, 30 January 2016 (diff | hist) . . (+20) . . Procainamide (→Pediatric Dosing)
- 11:43, 30 January 2016 (diff | hist) . . (+166) . . Procainamide (→Pediatric Dosing)
- 11:38, 30 January 2016 (diff | hist) . . (+91) . . Procainamide (→General)
- 11:35, 30 January 2016 (diff | hist) . . (+26) . . Procainamide (→General)
- 11:32, 30 January 2016 (diff | hist) . . (+16) . . Procainamide (→Arrythmia)
- 11:31, 30 January 2016 (diff | hist) . . (+83) . . Procainamide (→Arrythmia)
- 11:31, 30 January 2016 (diff | hist) . . (+12) . . ACLS: Tachycardia (→Wide Regular)
- 10:48, 30 January 2016 (diff | hist) . . (+22) . . Procainamide (→Arrythmia)
- 08:46, 30 January 2016 (diff | hist) . . (+116) . . EBQ:ED Preoxygenation (→Conclusion) (current)
- 05:43, 30 January 2016 (diff | hist) . . (+13) . . Congestive heart failure (→Heart Failure Without Pulmonary Edema)
- 11:01, 29 January 2016 (diff | hist) . . (+125) . . Digoxin toxicity (→Evaluation)
- 10:48, 29 January 2016 (diff | hist) . . (+246) . . Digoxin toxicity (→Evaluation)
- 10:23, 29 January 2016 (diff | hist) . . (-1) . . Digoxin toxicity (→Evaluation)
- 10:22, 29 January 2016 (diff | hist) . . (+72) . . Digoxin toxicity (→Evaluation)
- 10:17, 29 January 2016 (diff | hist) . . (+92) . . Digoxin toxicity (→Cardiac)
- 10:16, 29 January 2016 (diff | hist) . . (-80) . . Digoxin toxicity (→Management)
- 10:07, 29 January 2016 (diff | hist) . . (+126) . . Digoxin toxicity (→Management)
- 09:37, 29 January 2016 (diff | hist) . . (+5) . . Digoxin toxicity (→Risk Factors)
